Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy
|
Apr 2014
|
Hematol Oncol
|
myelodysplastic syndromes (MDS)
|
Paroxysmal Nocturnal Hemoglobinuria: A Complement-Mediated Hemolytic Anemia
|
Jun 2015
|
Hematol Oncol Clin North Am
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Bone Marrow Transplantation for Acquired Severe Aplastic Anemia
|
Dec 2014
|
Hematol Oncol Clin North Am
|
aplastic anemia
|
Transplants in Myelodysplastic Syndromes
|
Dec 2014
|
Hematol Oncol Clin North Am.
|
myelodysplastic syndromes (MDS)
|
Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis
|
Sep 2016
|
Hematol Rep
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Kinetics of Pre-Myelodysplastic Syndromes Blood Values Correlate with Disease Risk and Survival
|
Jul 2020
|
Hematological Oncology
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic syndromes with ring sideroblasts
|
Oct 2023
|
Hematological Oncology
|
myelodysplastic syndromes (MDS)
|
The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
|
Mar 2013
|
Hematology
|
myelodysplastic syndromes (MDS)
|
Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes
|
Jun 2016
|
Hematology
|
myelodysplastic syndromes (MDS)
|
Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece
|
Jan 2017
|
Hematology
|
myelodysplastic syndromes (MDS)
|